Page last updated: 2024-08-21

cepharanthine and Graves Disease

cepharanthine has been researched along with Graves Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Concepcion, E; Li, CW; Menconi, F; Osman, R; Tomer, Y	1

Other Studies

1 other study(ies) available for cepharanthine and Graves Disease

Article	Year
Cepharanthine blocks TSH receptor peptide presentation by HLA-DR3: Therapeutic implications to Graves' disease. Journal of autoimmunity, 2020, Volume: 108 Topics: Amino Acid Sequence; Animals; Antigen Presentation; Benzylisoquinolines; Epitope Mapping; Epitopes, T-Lymphocyte; Flow Cytometry; Graves Disease; HLA-DR3 Antigen; Humans; Immunohistochemistry; Lymphocyte Activation; Mice; Mice, Knockout; Mice, Transgenic; Models, Molecular; Peptide Fragments; Peptides; Protein Binding; Receptors, Thyrotropin; Structure-Activity Relationship; T-Lymphocytes	2020

Article

Year

Cepharanthine blocks TSH receptor peptide presentation by HLA-DR3: Therapeutic implications to Graves' disease.

Journal of autoimmunity, 2020, Volume: 108

Topics: Amino Acid Sequence; Animals; Antigen Presentation; Benzylisoquinolines; Epitope Mapping; Epitopes, T-Lymphocyte; Flow Cytometry; Graves Disease; HLA-DR3 Antigen; Humans; Immunohistochemistry; Lymphocyte Activation; Mice; Mice, Knockout; Mice, Transgenic; Models, Molecular; Peptide Fragments; Peptides; Protein Binding; Receptors, Thyrotropin; Structure-Activity Relationship; T-Lymphocytes

2020